Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it has submitted a Biologics License ...
Summit Therapeutics Inc. today announced it has entered into a clinical trial collaboration with GSK plc ("GSK", LSE/NYSE: GSK) to evaluate ivonescimab, a novel, investigational PD-1 / VEGF bispecific ...
HBO is no stranger to controversy. There's recently been all that hoo-ha about it changing its name from HBO Max to Max and ...
The political situation may be uncertain but that makes it even more important for brands to be proactive and identify trends ...
Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback